Fate Therapeutics Inc. (FATE) Dipped -5.77% or -0.98 To Price $16.0 On Thursday

Fate Therapeutics Inc. (FATE) dipped -5.77% or -0.98 to $16.0. It is nearly 406161 shares traded, which is 52.16% compare to the average total volume 778634. The market cap of FATE is $1.03 billion. The year to date change is 163.75%. The 52 week price range is from $3.8 to $17.98. Price of FATE have changed 23.49% during last week. It have changed 15.83% over last month, 34.98% over last 3 months, 49.08% over last 6 months N/A

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for FATE is 14.09. It is -11.94% below current price. The 200-day Moving Averages for FATE is 11.99. It is -25.06% below current price. The 52-week High is 17.98. It is 12.37% from the current price. The 52-week Low is 3.8. It is -76.25% from current price.

There are some statistics of FATE. It is has market cap $1.03 billion. The share outstanding is 64.52 million. The average volume is 778634. The percent of top 15 Institution holding is 131.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of FATE is -57.54%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of FATE is -43.21%.


Share this post